AI
CCCC icon

Atom Investors’s C4 Therapeutics CCCC Stock Holding History

Atom Investors’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$358K Buy
136,047
+31,083
+30% +$73.2K 0.03% 526
2025
Q4 		$200K Buy
+104,964
New +$249K 0.02% 502
2025
Q3 		– Sell
-190,182
Closed -$272K – 623
2025
Q2 		$272K Sell
190,182
-78,650
-29% -$114K 0.02% 457
2025
Q1 		$430K Buy
268,832
+167,148
+164% +$499K 0.05% 312
2024
Q4 		$366K Buy
+101,684
New +$506K 0.05% 345
2024
Q3 		– Sell
-332,620
Closed -$1.54M – 481
2024
Q2 		$1.54M Buy
332,620
+16,374
+5% +$97.7K 0.15% 191
2024
Q1 		$2.58M Buy
+316,246
New +$2.45M 0.32% 89
2022
Q3 		– Sell
-27,512
Closed -$207K – 299
2022
Q2 		$207K Buy
+27,512
New +$242K 0.09% 181

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return